Amniotic Membrane Market
Amniotic Membrane Market Study by Cryopreserved and Dehydrated Amniotic Membranes for Surgical Wounds and Ophthalmology from 2024 to 2034
Analysis of Amniotic Membrane Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Amniotic Membrane Market Outlook (2024 to 2034)
Revenue from the global amniotic membrane market is estimated to reach US$ 2.95 billion in 2024. The market has been analyzed to climb to a value of US$ 7.55 billion by the end of 2034, expanding at a CAGR of 9.9% over the next ten years (2024 to 2034).
Amniotic membrane graft refers to a surgical procedure in which a thin, transparent membrane derived from the innermost layer of the placenta (amniotic membrane) is used as a graft or patch to treat various medical conditions. Amniotic membrane grafts for ophthalmic surgery ensure the efficient management of ocular surface disorders, corneal defects, conjunctival reconstruction, and other eye-related conditions.
Key Market Growth Drivers
- Growing demand for tissue-based products in ophthalmic surgeries, due to their rapid recovery benefits, is contributing to the expansion of the amniotic membrane market size. Additionally, rising need for surgeries aimed at enhancing aesthetic appeal is projected to benefit market players during the forecast period.
- Advancements in cryopreservation techniques, bioengineering and tissue engineering, biocompatible scaffolds, amniotic fluid-derived products, and topical formulations are some of the most significant developments in amniotic membrane technology. These innovations are enhancing tissue repair, regeneration, and therapeutic modulation.
- According to the American Society of Plastic Surgeons, there were approximately 17.7 million cosmetic procedures performed in 2018. Furthermore, the increasing prevalence of ocular disorders is expected to generate demand for wound care techniques such as amniotic membrane transplants.
- A CDC report revealed that around 1 million people in the United States suffer from eye infections annually. Moreover, there are increasing efforts to enhance the effectiveness of amniotic membranes. For instance, Surgenex has developed SurGraft, a dehydrated amniotic membrane that provides better shelf-life to improve the longevity of the amniotic membrane.
- Violations of road safety regulations and rising traffic congestion incidents are driving up accident rates worldwide. Consequently, the increase in accidents and trauma cases is boosting the use of amniotic membranes in related procedures. According to a World Health Organization (WHO) report published in June 2022, approximately 1.3 million deaths occur each year due to road traffic accidents.
- Amniotic membranes can heal tissue damage and provide anti-inflammatory properties. They are also used in severe dry eye cases where chronic lack of tears has resulted in corneal damage (keratitis).
| Report Attributes | Details |
|---|---|
| Amniotic Membrane Market Size (2024 E) | US$ 2.95 Billion |
| Projected Market Value (2034 F) | US$ 7.55 Billion |
| Global Market Growth Rate (2024 to 2034) | 9.9% CAGR |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 12.1% CAGR |
| North America Market Growth Rate (2034) | 12% CAGR |
| Revenue from Hospitals Segment (2024) | US$ 1.06 Billion |
| Revenue from Surgical Wounds Segment (2024) | US$ 1.18 Billion |
| Key Companies Profiled | Alliqua BioMedical Inc.; Amnio Technology LLC; Applied Biologics LLC; Human Regenerative Technologies LLC; DermaSciences; Katena Products Inc.; MiMedx Group Inc.; Skye Biologics Inc.; Amniox Medical Inc.; Integra LifeSciences Corporation; MiMedx Group, Inc.; Skye Biologics Holdings, LLC. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How are Technological Innovations in Surgery Boosting Use of Amniotic Membranes?
“Preference for Amniotic Tissue Grafts in Wound Healing During Complex Surgeries”
Unique properties of the amniotic membrane make it indispensable in stem cell biology research. Serving as a substrate for stem cell culture, it fosters an optimal environment for cell proliferation, differentiation, and tissue regeneration investigations. Stem cell biology research aims to enhance regenerative medicine, disease modeling, and drug discovery.
Rising investments in research and development are fueling advancements in the healthcare sector. Consequently, the upsurge in stem cell biology research is propelling amniotic membrane market growth. Ongoing technological innovations in the surgical domain and the increasing utilization of amniotic membranes in regenerative medicine are poised to propel market growth. Amniotic tissue grafts facilitate wound healing in intricate surgeries, making them a staple for surgeons.
Which Factors are Inhibiting Adoption of Amniotic Membrane Treatments?
“High Treatment Cost and Elevated Risk of Infections”
High costs of amniotic membrane treatment are hindering market growth to some extent. Moreover, the risk of infections linked to amniotic membrane application is impacting market growth.
- According to a study published in the Clinical Ophthalmology Journal in 2020, there's an increased risk of contracting diseases such as Hepatitis C, Hepatitis B, HIV, and Prion.
Complications associated with amniotic membranes, such as the development of hematomas, granulomas, and hypopyon, are posing further barriers to market growth. Furthermore, the inadequate classification system for clinical conditions further restricts market expansion forecasts.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is projected to hold a significant amniotic membrane market share during the forecast period due to the increasing demand for amniotic eye treatment. The region is estimated to hold a market share of 12% in 2024. Europe is also emerging as a lucrative market for amniotic membrane suppliers. The expansion of the market in Europe is attributed to the extensive adoption of advanced healthcare systems.
- The World Health Organization (WHO) revealed that diseases such as diabetes, cancer, cardiovascular disease, and chronic respiratory ailments claim about 86% of lives in the European region. Therefore, there has been a significant rise in demand for efficient methods to reduce fatalities and counter diseases, thereby expanding the market in the region.
How is Demand for Amniotic Membranes Shaping Up in the United States?
“Market Benefitting from Advancements in Regenerative Medicine”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 902.2 Million |
| Growth Rate (2024 to 2034) | 11.4% CAGR |
| Projected Value (2034F) | US$ 2.66 Billion |
The United States is set to hold 87.6% share of the North American market in 2024. Advancements in regenerative medicine, the increasing prevalence of ophthalmological disorders, rising investments in healthcare research and development, and the growing popularity of aesthetic surgeries are important amniotic membrane market trends in the country. In addition, use of amniotic membranes in wound care during complex surgeries is rising at a significant pace.
- According to the data published by the United States Centers for Medicare & Medicaid Services in February 2023, national healthcare expenditures increased by 2.7% to US$ 4.3 trillion in 2021 versus 2020.
Why are Amniotic Membrane Providers Turning Their Attention toward Japan?
“Rising Prevalence of Chronic Wounds among Elders and Well-established Medical Infrastructure”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 163.2 Million |
| Growth Rate (2024 to 2034) | 3.8% CAGR |
| Projected Value (2034F) | US$ 236.1 Million |
Japan has an increasing elderly population susceptible to age-related conditions such as ocular disorders and chronic wounds. Thus, there is a greater need for advanced wound care solutions like amniotic membranes. Japan boasts a well-developed healthcare system with advanced medical facilities and a strong emphasis on innovation. This infrastructure is boosting the adoption of cutting-edge treatments like amniotic membrane therapy.
Category-wise Insights
In terms of product type, the cryopreserved amniotic membranes segment is expected to account for 54.8% in 2024. Similarly, the surgical wounds segment is expected to generate significant revenue in terms of application in 2024.
What is the Primary Application of Amniotic Membranes?
“Anti-inflammatory Agents in Amniotic Membranes Facilitating Healing of Surgical Wounds”
| Attribute | Surgical Wounds |
|---|---|
| Segment Value (2024E) | US$ 1.18 Billion |
| Growth Rate (2024 to 2034) | 10.3% CAGR |
| Projected Value (2034F) | US$ 3.17 Billion |
Based on application, the market can be segmented into surgical wounds, ophthalmology, and others. As per the estimations from Fact.MR, the surgical wounds segment is expected to procure a significant revenue share of 40% in 2024.
Expansion of the segment is attributed to the increasing incidence of infectious and chronic diseases. In addition, the growing number of cosmetic surgeries is also a significant driver for market growth. They contain growth factors and anti-inflammatory agents that promote tissue regeneration, reduce inflammation, and accelerate healing.
Why are Hospitals preferred by Patients for Amniotic Membrane-based Treatments?
“Availability of Specialized Expertise and Equipment in Hospitals”
| Attribute | Hospitals |
|---|---|
| Segment Value (2024E) | US$ 1.06 Billion |
| Growth Rate (2024 to 2034) | 10.4% CAGR |
| Projected Value (2034F) | US$ 2.86 Billion |
Based on end use, the hospital segment is poised to hold 36.2% of the market share in 2024. The growth of the segment is attributed to the increasing number of visits by patients to the hospital to procure primary health care facilities. Hospitals are chosen for amniotic membrane treatments due to their comprehensive medical facilities, specialized expertise, and stringent regulatory standards. Hospitals provide a controlled environment conducive to administering and monitoring advanced therapies like amniotic membrane treatments.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
Key players in the amniotic membrane market are increasing investments in research and development, allowing companies to create innovative products to meet customer demands. Conducting multiple clinical trials helps companies seek product approvals.
- In February 2022, Amnio Technology introduced two new membrane products: PalinGen Dual-Layer Membrane and Dual-Layer PalinGen X-Membrane. These new allografts, like the rest of the PalinGen membrane products, are minimally processed, homologous compatible, and free of chorion. These allografts, with their dual-layer design, can be applied in a single direction and have two outer epithelial sides.
- In September 2022, MiMedx Group, Inc., a leading producer of placental biologics, launched Amnioeffect, composed of an amnion layer, chorion layer, and intermediate membrane layer.
Fact.MR provides detailed information about the price points of significant providers of amniotic membranes positioned across the world, sales growth, production capacity, and speculative technological expansion, in this updated market report.
Segmentation of Amniotic Membrane Market Research
-
By Product :
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
-
By Application :
- Surgical Wounds
- Ophthalmology
- Other Applications
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research & Academic Institutes
-
By Region :
- North America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Latin America
- Middle East & Africa
- FAQs -
How big is the amniotic membrane market in 2024?
The global amniotic membrane market estimated to be valued at US$ 2.95 billion in 2024.
What are the sales projections for amniotic membranes over the decade?
The global market is forecasted to expand at 9.9% CAGR to reach US$ 7.55 billion by 2034.
Which country has a significant market for amniotic membranes?
The United States is estimated to reach a market value of US$ 902.2 million in 2024.
What is the market size of amniotic membranes in China?
The market in China is forecasted to reach US$ 825.7 million by 2034.
How much is the sales of amniotic membranes in hospitals?
The hospitals segment is expected to be valued at US$ 1.06 billion in 2024.
What is the share of Japan in the East Asia market?
Japan accounts for 30.4% market share in East Asia in 2024.
Who are the leaders in the business of amniotic membranes?
Amnio Technology LLC, DermaSciences, Katena Products Inc., MiMedx Group Inc., Skye Biologics Inc., and Amniox Medical Inc. are key players in this market.
Amniotic Membrane Market